Clinical trials of anticoagulants and anticoagulant factor concentrates for the management of DIC in Japan
Okamoto, K.; Tamura, T.; Yamaguchi, K.
Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 95-103
2011
ISSN/ISBN: 0047-1860 PMID: 21761755 Document Number: 655982
Document emailed within 1 workday
Related Documents
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518Fukutake, K. 2000: Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan Seminars in Thrombosis and Hemostasis 26(1): 29-32
Amblard, P.; Reymond, J.L.; Beani, J.C.; Pouzol, P.; Carpentier, P. 1981: Acquired anticoagulants of immunologic origin: association of circumscribed pemphigoid and an anti-factor VIII anticoagulant La Nouvelle Presse Medicale 10(31): 2584-2585
Anderson, J.; O'Donnell, M. 2006: Clinical trials of new anticoagulants Vnitrni Lekarstvi 52(Suppl 1): 123-126
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Lusher, J.M. 1993: Prediction and management of adverse events associated with the use of factor IX complex concentrates Seminars in Hematology 30(2 Suppl. 1): 36-40
Nyman, D. 1975: Clinical use of factor IX concentrates Schweizerische Medizinische Wochenschrift 105(37): 1188-1190
Imanishi, J.; Kishida, T. 1981: Clinical trials with interferon in Japan Texas Reports on Biology and Medicine 41: 647-652
Takaku, F. 1984: Clinical trials and cancer risk in Japan Journal of the National Cancer Institute 73(6): 1483-1485
Nakagawa, K. 2007: International clinical trials for a medical oncologist in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 320-323
Sie, P.; Bouget, J.; Boulain, T.; Castot, A.; Dumarcet, N.; Druais, P-Louis.; Gruel, Y.; Helft, G.; Huas, D.; Iung, B.; Laroche, J-Pierre.; Leger, P.; Mahe, I.; Pavie, A.; Pelladeau, A.; Roy, P-Marie.; Samama, C-Marc. 2008: Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting--April 2008 Journal des Maladies Vasculaires 33(4-5): 202-213
Watanabe, T.; Handa, S.; Kato, Y. 2015: Emetogenic potential of antineoplastic agents based on clinical trials in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(3): 335-341
Latallo, Z.S.; Malanowicz, W. 1970: Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants Kardiologia Polska 13(4): 351-358
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Hofmann, V.; Ermanni, M.; Straub, P.W. 1978: Thrombin formation in factor IX concentrates and FEIBA (factor eight inhibitor bypassing activity) (proceedings) Schweizerische Medizinische Wochenschrift 108(41): 1600
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Van Wijk, E.M.; Kahlé, L.H.; ten Cate, J.W. 1980: Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants Clinical Chemistry 26(7): 885-890
Cadroy, Y.; Sié, P.; Alhenc-Gelas, M.; Aiach, M. 1995: Evaluation of APC resistance in the plasma of patients with Q506 mutation of factor V (factor V Leiden) and treated by oral anticoagulants Thrombosis and Haemostasis 73(4): 734-735
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27